Christopher Austin
March 19, 2021 07:26 AM EDT
People

Christo­pher Austin makes his re­turn to in­dus­try, jump­ing ship from NIH over to CEO-part­ner role at Flag­ship

Nicole DeFeudis

Editor

Flag­ship Pi­o­neer­ing has plucked its lat­est hire straight from the ranks of the NIH.

Af­ter near­ly two decades at the NIH and al­most 10 years …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Up­dat­ed: Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force as CEO de­parts

In sur­prise move, FDA's No. 2 Bum­pus to leave agency at end of 2024

Ex­clu­sive: In­sitro makes head­way on the hard­er road, dis­cov­er­ing new ALS drug tar­get

No­vo Nordisk part­ners with Broad In­sti­tute spin­out Pho­tys af­ter the star­tup's lay­offs

Tessera gets up to $50M from the Gates Foun­da­tion; Tvar­di’s re­verse merg­er

A service from the Financial Times